VKH
IBB icon

Virtu KCG Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Virtu KCG Holdings’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-10,098
Closed -$893K – 3402
2016
Q4 		$893K Sell
10,098
-13,071
-56% -$1.19M 0.02% 872
2016
Q3 		$2.23M Sell
23,169
-99,162
-81% -$9.43M 0.05% 266
2016
Q2 		$10.5M Buy
122,331
+71,112
+139% +$6.38M 0.22% 24
2016
Q1 		$4.45M Buy
51,219
+43,083
+530% +$3.85M 0.13% 72
2015
Q4 		$918K Sell
8,136
-21,345
-72% -$2.32M 0.02% 940
2015
Q3 		$2.98M Buy
29,481
+24,963
+553% +$2.99M 0.05% 265
2015
Q2 		$556K Sell
4,518
-5,910
-57% -$707K 0.01% 1392
2015
Q1 		$1.19M Buy
+10,428
New +$1.15M 0.02% 651
2014
Q4 		– Sell
-3,135
Closed -$286K – 3941
2014
Q3 		$286K Sell
3,135
-8,070
-72% -$708K 0.01% 2427
2014
Q2 		$959K Buy
+11,205
New +$883K 0.01% 1215
2013
Q4 		– Sell
-14,562
Closed -$1.02M – 3971
2013
Q3 		$1.02M Buy
+14,562
New +$954K 0.01% 1160

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Virtu KCG Holdings's IBB Position: Q1 2017 in Review

Virtu KCG Holdings sold out of iShares Biotechnology ETF (IBB) in Q1 2017, closing a stake of 10,098 shares — an estimated $893K sold.

Virtu KCG Holdings first reported a position in IBB in Q3 2013 and held it in 11 quarters. The position peaked at $10.5M in Q2 2016. 521 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

  • Virtu KCG Holdings reported no remaining iShares Biotechnology ETF position as of Q1 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 10,098 iShares Biotechnology ETF shares in Q1 2017, an estimated $893K.
  • Virtu KCG Holdings first reported a position in iShares Biotechnology ETF in Q3 2013 and held it in 11 quarters.
  • Virtu KCG Holdings's iShares Biotechnology ETF position peaked at $10.5M in Q2 2016.
  • 521 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Virtu KCG Holdings's 13F filing for Q1 2017, filed 12 May 2017.